Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice
Introduction and objective: ziconotide is the first-in-class drug of selective N-type voltage-sensitive calcium-channel blockers used to control severe chronic pain. The present study is developed in order to analyze clinical and economical outcomes of spinal neuromodulation with ziconotide continuo...
Main Authors: | Orietta Zaniolo, Sergio Iannazzo, Gian Piero Patrucco, Roberto Bellini |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2011-06-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/74 |
Similar Items
-
Lumbar neuropathic pain of lower limbs treated by spinal infusion of ziconotide a case – report
by: Luca Quadrino
Published: (2008-09-01) -
Ziconotide in severe, drug-resistant cancer pain. preliminary experience
by: Angelo Lavano
Published: (2008-12-01) -
Serious pain treatment with intrathecal ziconotide pathway - clinical case
by: Giovanni Nicotera, et al.
Published: (2008-04-01) -
Intracisternal ziconotide infusion. Clinical case of an inoperable pharynx cancer patient with severe cervico-facial pain syndrome
by: Sergio Mameli, et al.
Published: (2015-03-01) -
Intrathecal pain management with ziconotide: Time for consensus?
by: Georgios Matis, et al.
Published: (2021-03-01)